Psychiatria Spersonalizowana

Abstract

1/2025 vol. 4
Case report

Integrated treatment of treatment-resistant depression – a case study of Ericksonian psychotherapy assisted by intravenous ketamine

  1. Pracownia E. Weatherwax Szymon Niemiec, Warszawa; E. Weatherwax Szymon Niemiec Workshop, Warsaw
Personalized Psychiatry 2025; 4: e76–e79
Online publish date: 2025/08/26
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
The article presents a case study of a 22-year-old female patient suffering from severe, treatment-resistant depression who did not respond to standard pharmacological treatments and psychotherapy. An integrated, three-phase therapeutic model was implemented, combining Ericksonian psychotherapy with intravenous ketamine infusions. The treatment process included a preparatory phase, a series of 12 ketamine infusions, and a six-month integration therapy phase. In this approach, the altered state of consciousness induced by ketamine was utilized as a therapeutic trance, which facilitated bypassing the patient’s rigid cognitive patterns and accessing her unconscious resources. The therapy resulted in a significant and lasting reduction in symptoms of depression and anxiety, confirmed by both quantitative and qualitative analysis. The author concludes that the synergy between a biological intervention (ketamine) and psychotherapy, based on preparation, a catalytic intervention, and integration, represents a promising, personalized method for treating severe mental disorders.
Share
without publication fees
without publication fees